Treatment Indications: volumetric restoration of midface, cheeks, and chin;, structural contouring of cheekbones,, jawline, and temple zones; correction of severe facial volume loss and deep tissue depressions;, ; 3D facial modeling requiring a high‑support, cohesive gel with elevated G’ for stable, long‑lasting results;, restoration of youthful facial proportions in cases of pronounced atrophy
Release form: 1 × 1.1 mL pre‑filled syringe
Compound: cross‑linked hyaluronic acid (non‑animal origin, produced via biofermentation) with dual‑density cross‑linking technology for enhanced structural integrity; lidocaine hydrochloride; phosphate‑buffered saline solution
Concentration of GC: 20 mg/mL
Lidocaine: 0.3%
Indications: deep dermal to subdermal volumization in high‑movement and high‑support zones;, correction of deep nasolabial folds, marionette lines, and glabellar folds with volumetric support;, sharp contour definition where minimal gel migration and maximal shape retention are required;, architectural facial reshaping and augmentation of flat or recessed areas